| Information |  | |
Derechos | Equipo Nizkor
| ||
| Information | | |
Derechos | Equipo Nizkor
| ||
24Oct14
Hundred of thousands of Ebola vaccines may ready in 2015: WHO
Assistant Director-General of World Health Organization (WHO) Marie-Paule Kieny on Friday said hundred of thousands of Ebola vaccines might be ready to use in first half of 2015 to turn the tide against the deadly Ebola epidemic.
On Thursday, WHO convened a meeting of government representatives, vaccine manufacturers, funding agencies and civil society, to discuss how to quicken the testing and deployment of promising vaccines in sufficient numbers to use in the field in 2015.
"Phrase 1 of clinical trials of two most advanced vaccines have been started, the result of these trials will be available in December 2014," Kieny told a press conference at WHO's headquarters in Geneva.
Kieny said the trials of the two most advanced vaccines, cAd3-ZEBOV and rVSV-ZEBOV, developed by GSK and Public Health Agency of Canada respectively, have begun in Britain, the United States and Mali, and will shortly begin in Switzerland, Germany, Gabon and Kenya.
She noted that at least five more vaccines are following up closely, which will be in the clinic in the first month of 2015.
She said pharmaceutical companies that are developing the vaccines are committed to increasing the production capacity to millions of doses in 2015, with hundred of thousands ready in the first half of next year.
"To make this a reality, regulatory authorities in countries where vaccines are manufacturing and in Africa will need to work closely with manufacturers, to extremely shorten timelines and to find way to overcome the number of furthers," she added.
"Vaccines are not a magic bullet, but when ready they may be a good part of the effort to turn the tide against the epidemic," she said.
[Source: Xinhua, Geneva, 24Oct14]
 | This document has been published on 27Oct14 by the Equipo Nizkor and Derechos Human Rights. In accordance with Title 17 U.S.C. Section 107, this material is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. |